Ware, Russell E.
Indiana University Health · Cincinnati Children's Hospital Medical Center · Mulago Hospital · Indiana University Indianapolis · Indiana University – Purdue University Indianapolis · University of Cincinnati · Makerere University
11 papers on CoChatORCID 0000-0001-9582-0594
Most cited papers
- Verified
Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members
Yawn, B. P., Buchanan, G. R., Afenyi-Annan, A. N., Ballas, S. K., Hassell, K. L., James, A. H., Jordan, L., Lanzkron, S. M., Lottenberg, R., Savage, W. J., et al. (2014) · JAMA
Hemoglobinopathies and Related DisordersHemophilia Treatment and Research
Cited by 1,599
- Verified
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., et al. (2000) · New England Journal of Medicine
Hemoglobinopathies and Related DisordersBlood transfusion and management
Cited by 1,234
- Verified
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
Wang, W. C., Ware, R. E., Miller, S. T., Iyer, R. V., Casella, J. F., Minniti, C. P., Rana, S., Thornburg, C. D., Rogers, Z. R., Kalpatthi, R. V., et al. (2011) · The Lancet
Hemoglobinopathies and Related DisordersNeonatal Health and Biochemistry
Cited by 803
- Verified
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial
Ware, R. E., Davis, B. R., Schultz, W. H., Brown, R. C., Aygun, B., Sarnaik, S., Odame, I., Fuh, B., George, A., Owen, W., et al. (2016) · The Lancet
Hemoglobinopathies and Related DisordersNeonatal Health and Biochemistry
Cited by 515
- Verified
Hydroxyurea for children with sickle cell anemia in Sub-Saharan Africa
Tshilolo, L., Tomlinson, G., Williams, T. N., Santos, B., Olupot-Olupot, P., Lane, A., Aygun, B., Stuber, S. E., Latham, T. S., McGann, P. T., et al. (2019) · New England Journal of Medicine
Hemoglobinopathies and Related DisordersBlood groups and transfusion
Cited by 376
- Verified
In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology
Tsai, M., Kita, A., Leach, J., Rounsevell, R., Huang, J. N., Moake, J., Ware, R. E., Fletcher, D. A., & Lam, W. A. (2012) · Journal of Clinical Investigation
Blood properties and coagulation3D Printing in Biomedical Research
Cited by 297
- Verified
Hydroxyurea dose escalation for sickle cell anemia in Sub-Saharan Africa
John, C. C., Opoka, R. O., Latham, T. S., Hume, H. A., Nabaggala, C., Kasirye, P., Ndugwa, C. M., Lane, A., & Ware, R. E. (2020) · New England Journal of Medicine
Hemoglobinopathies and Related DisordersMalaria Research and Control
Cited by 153
- Verified
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia
McGann, P. T., Niss, O., Dong, M., Marahatta, A., Howard, T. A., Mizuno, T., Lane, A., Kalfa, T. A., Malik, P., Quinn, C. T., et al. (2019) · American Journal of Hematology
Hemoglobinopathies and Related DisordersPharmaceutical studies and practices
Cited by 105
- Verified
A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy
Estepp, J. H., Smeltzer, M. P., Kang, G., Li, C., Wang, W. C., Abrams, C., Aygun, B., Ware, R. E., Nottage, K., & Hankins, J. S. (2017) · American Journal of Hematology
Hemoglobinopathies and Related DisordersBlood groups and transfusion
Cited by 88
- Verified
Effects of hydroxyurea treatment for patients with hemoglobin SC disease
Luchtman‐Jones, L., Pressel, S., Hilliard, L., Brown, R. C., Smith, M. G., Thompson, A. A., Lee, M. T., Rothman, J., Rogers, Z. R., Owen, W., et al. (2016) · American Journal of Hematology
Hemoglobinopathies and Related DisordersHemophilia Treatment and Research
Cited by 86
- Verified · note
From Infancy to Adolescence: Fifteen Years of Continuous Treatment With Hydroxyurea in Sickle Cell Anemia
Hankins, J. S., Aygun, B., Nottage, K., Thornburg, C., Smeltzer, M. P., Ware, R. E., & Wang, W. C. (2014) · Medicine
Hemoglobinopathies and Related DisordersNeonatal Health and Biochemistry
Cited by 77
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free